Biology, models, and the analysis of tumor xenograft experiments

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Advances in statistical modeling and analysis technology have improved our ability to derive valid inferences from tumor xenograft experiments. Further challenges in this area include the modeling of intertumor heterogeneity and the development of robust statistical models that describe key parameters in the underlying tumor biology.

Original languageEnglish (US)
Pages (from-to)949-951
Number of pages3
JournalClinical Cancer Research
Volume17
Issue number5
DOIs
StatePublished - Mar 1 2011

Fingerprint

Heterografts
Statistical Models
Neoplasms
Technology

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Biology, models, and the analysis of tumor xenograft experiments. / Heitjan, Daniel F.

In: Clinical Cancer Research, Vol. 17, No. 5, 01.03.2011, p. 949-951.

Research output: Contribution to journalArticle

@article{1e60e51357ab4d068c7c4499ef055dfc,
title = "Biology, models, and the analysis of tumor xenograft experiments",
abstract = "Advances in statistical modeling and analysis technology have improved our ability to derive valid inferences from tumor xenograft experiments. Further challenges in this area include the modeling of intertumor heterogeneity and the development of robust statistical models that describe key parameters in the underlying tumor biology.",
author = "Heitjan, {Daniel F.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1158/1078-0432.CCR-10-3279",
language = "English (US)",
volume = "17",
pages = "949--951",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Biology, models, and the analysis of tumor xenograft experiments

AU - Heitjan, Daniel F.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Advances in statistical modeling and analysis technology have improved our ability to derive valid inferences from tumor xenograft experiments. Further challenges in this area include the modeling of intertumor heterogeneity and the development of robust statistical models that describe key parameters in the underlying tumor biology.

AB - Advances in statistical modeling and analysis technology have improved our ability to derive valid inferences from tumor xenograft experiments. Further challenges in this area include the modeling of intertumor heterogeneity and the development of robust statistical models that describe key parameters in the underlying tumor biology.

UR - http://www.scopus.com/inward/record.url?scp=79952264228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952264228&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-10-3279

DO - 10.1158/1078-0432.CCR-10-3279

M3 - Article

C2 - 21224374

AN - SCOPUS:79952264228

VL - 17

SP - 949

EP - 951

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 5

ER -